What Did This CEO Just Do with Personal Shares of Xenon (NASDAQ: XENE)?

By Carrie Williams

Today, the CEO of Xenon (XENEResearch Report), Simon Pimstone, sold shares of XENE for $98.86K.

Following Simon Pimstone’s last XENE Sell transaction on March 14, 2018, the stock climbed by 4.5%. In addition to Simon Pimstone, 3 other XENE executives reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

The company has a one-year high of $13.60 and a one-year low of $5.41. Currently, Xenon has an average volume of 79.06K.

The insider sentiment on Xenon has been negative according to 14 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Xenon Pharmaceuticals, Inc. engages in discovering and developing therapeutics to improve the lives of patients with neurological disorders. It focuses on the treatment of epilepsy. Its products include XEN496, XEN1101, XEN901, and XEN007.